Kukje Pharma Co Ltd (002720) — Cash Flow-to-Debt Ratio
Kukje Pharma Co Ltd (002720) has a Cash Flow-to-Debt Ratio of 0.06x as of September 2025, meaning its operating cash flow of ₩4.99 Billion could theoretically repay 0% of its total liabilities (₩84.80 Billion) in one year. Explore Kukje Pharma Co Ltd (002720) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Kukje Pharma Co Ltd Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Kukje Pharma Co Ltd across 14 annual periods. Also explore Kukje Pharma Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Kukje Pharma Co Ltd (2011–2024)
Year-by-year debt coverage analysis for Kukje Pharma Co Ltd. For market capitalisation and broader financial context, see Kukje Pharma Co Ltd market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.05x | ₩3.94 Billion | ₩76.00 Billion | ▲ +13.6% |
| 2023 | 0.05x | ₩3.58 Billion | ₩78.31 Billion | ▼ -56.1% |
| 2022 | 0.10x | ₩6.50 Billion | ₩62.51 Billion | ▼ -22.8% |
| 2021 | 0.13x | ₩9.60 Billion | ₩71.20 Billion | ▲ +98.6% |
| 2020 | 0.07x | ₩5.10 Billion | ₩75.13 Billion | ▲ +38.7% |
| 2019 | 0.05x | ₩3.60 Billion | ₩73.64 Billion | ▼ -78.7% |
| 2018 | 0.23x | ₩13.25 Billion | ₩57.54 Billion | ▲ +1770.8% |
| 2017 | 0.01x | ₩786.10 Million | ₩63.87 Billion | ▼ -95.3% |
| 2016 | 0.26x | ₩16.10 Billion | ₩61.94 Billion | ▲ +448.9% |
| 2015 | -0.07x | ₩-5.08 Billion | ₩68.18 Billion | ▼ -8026.7% |
| 2014 | 0.00x | ₩-61.11 Million | ₩66.66 Billion | ▲ +98.8% |
| 2013 | -0.08x | ₩-4.60 Billion | ₩59.10 Billion | ▼ -393.2% |
| 2012 | 0.03x | ₩1.58 Billion | ₩59.57 Billion | ▼ -89.8% |
| 2011 | 0.26x | ₩17.39 Billion | ₩66.82 Billion | — |